Skip to main content
Featured products
OSYPKA PACE 101H® is a single-chamber external pacemaker ideal for temporary cardiac pacing in…
Temporary myocardial pacing cables intended for use after cardiac surgery. Available in multiple…
CoraSim® is a heart simulator designed for training and education in cardiac electrophysiology…

    News

    Discover our events, collaborations, and advances in clinical diagnostics, technological innovation, and specialised medical training.

    ECMO in Spain: present and future

    ECMO in Spain: present and future

    Extracorporeal membrane oxygenation (ECMO) support has become established in recent years as one of the most advanced therapies for the treatment of critically ill patients with severe respiratory or cardiac failure. However, its growing implementation across hospitals in Spain is creating new organisational challenges for the healthcare system.

    This was one of the central themes discussed during the 1st ECMO Update Conference in Spain. Held on 26 February at the Ramón y Cajal University Hospital in Madrid and organised by the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the event brought together national and international specialists to analyse the current situation of extracorporeal support in Spain and to share clinical, organisational and training experiences.

    A highly complex therapy on the rise

    ECMO is an extracorporeal life support technique that temporarily replaces the function of the heart and/or lungs through an external circuit that oxygenates the blood and returns it to the body. It is used in critical situations such as severe respiratory failure, cardiogenic shock or refractory cardiac arrest, when conventional treatments are no longer sufficient.

    In Spain, the development of specialised intensive care medicine programmes focused on ECMO has progressed significantly. This growth, led by multidisciplinary teams, has made it possible to expand clinical indications and dramatically improve the care provided to critically ill patients.

    The current challenge: organising the healthcare system

    During the conference, several specialists highlighted that the expansion of ECMO programmes has not always been accompanied by coordinated regional planning. According to the experts, the current organisation varies between Spain’s autonomous communities, creating differences in coverage, coordination between centres and critical care patient transport models.

    In response to this situation, professionals from SEMICYUC stressed the need to move towards a structured national strategy for adult ECMO support, with the aim of ensuring:

    • Equal access to therapy throughout the country.
    • Consistency in healthcare quality standards.
    • Sustainability of the public healthcare system.

    International models show that the creation of reference centres, clearly defined referral networks and specialised transport systems helps to improve patient safety and the efficiency of clinical outcomes.

    Training, research and care coordination

    Another key topic discussed was the importance of strengthening national registries, outcome auditing and specialised ECMO training programmes. Collaboration between hospitals, scientific societies and healthcare authorities is considered essential for consolidating this advanced therapy.

    Spain has highly qualified professionals in intensive care. The current challenge lies in improving organisational coordination in order to guarantee equal access and maintain high standards of quality in the management of critically ill patients.

    Source: Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC)

    Spain maintains its global leadership in organ transplantation in 2025 thanks to medical innovation and advanced technologies

    Spain maintains its global leadership in organ transplantation in 2025 thanks to medical innovation and advanced technologies

    Spain has once again reaffirmed its position as a global leader in organ transplantation, surpassing 6,300 procedures carried out in 2025, with a rate of 51.9 donors per million population. These figures consolidate the Spanish healthcare model and its firm commitment to organ donation and transplantation.
    >According to data presented by the National Transplant Organisation (ONT), 6,335 organ transplants were performed in 2025, keeping Spain at the top internationally for the second consecutive year in a medical activity of high complexity and enormous social impact.

    Technological innovation and advanced organ preservation

    One of the key factors behind this leadership is the adoption and widespread use of organ preservation procedures using extracorporeal circulation devices (ECMO). This advanced technology makes it possible to maintain the viability of organs suitable for transplantation. Even in highly complex clinical situations, leading to improved clinical outcomes and expanding therapeutic options for patients.

    Cardiac transplantation after circulatory death: a clinical milestone

    Due to its particular technical complexity, only nine countries worldwide successfully carry out this type of procedure. In Spain, cardiac transplantation after circulatory death, performed following the donor’s cardiorespiratory arrest, now accounts for 35% of all heart transplants. This figure reflects the high level of clinical and technological development of the Spanish transplant system.

    A strong and coordinated healthcare system

    In addition to heart transplantation, kidney, liver, lung and other specialised transplants have contributed to maintaining exceptional donation and transplantation figures. All of this is the result of a robust, well-coordinated healthcare system with a long-standing record of excellence in this field.

    Organisational model, solidarity and innovation

    The combination of an efficient organisational model, a strong culture of solidarity and technological advances such as ECMO systems has enabled Spain not only to maintain. Also to continue strengthening its global leadership in organ transplantation, setting the benchmark for advanced medicine and healthcare innovation.

    Biogen Diagnóstica, official sponsor of Tacit Meeting 2025 in Valencia

    Biogen Diagnóstica, official sponsor of Tacit Meeting 2025 in Valencia

    The upcoming 12 and 13 November 2025, the Hospital La Fe de Valencia will host one of the most outstanding events of the year in the field of interventional cardiology, Tacit Meeting 2025, and Biogen Diagnóstica will participate as one of the 12 official sponsors.

    This event will bring together interventional cardiologists from around the world to share experiences, knowledge, and the latest innovations in structural heart interventions. With 7 international speakers, 6 live clinical cases over 2 days of intensive practical training, the event aims to provide an advanced learning tool for professionals already experienced in structural therapies.

    The scientific direction will be led by three international authorities:

    Dr Ignacio J. Amat Santos Hospital Clínico Universitario de Valladolid, Spain Dr Jorge Sanz Hospital La Fe de Valencia, Spain Dr Jaffar Khan St. Francis Hospital and Heart Center, New York, USA
    The international faculty panel includes:

    Dr Pier Pasquale Leone Montefiore Medical Center, New York, USA Dr Marcio Montenegro Heart Valve Center, Rio de Janeiro, Brazil Dr Arif Khokhar The Heart Center, Rigshospitalet, Copenhagen, Denmark Dr Ander Regueiro Hospital Clínic de Barcelona, Spain Dr Philip Freeman Karolinska Heart Centre, Stockholm, Sweden

    At Biogen Diagnóstica, we believe that innovation and specialised training are essential to advancing cardiovascular healthcare. Supporting initiatives like this reflects our commitment to medical progress, clinical excellence, and continuous improvement in interventional cardiology procedures.

    Dates

    12 and 13 November 2025

    Venue

    Hospital La Fe de Valencia

    Registration

    Register here